Ispire Technology Inc. Reports 24.7% Revenue Decline and $33.2 Million Net Loss for Fiscal Year Ending June 30, 2026

Ispire Technology Inc. reported a significant decline in financial performance for the fiscal year ending June 30, 2026, with total revenue of $96.0 million, a decrease of 24.7% from $127.5 million in the previous year. The company attributed this drop primarily to reduced sales in North America and Europe, driven by stricter payment terms and regulatory uncertainties. The net loss for the year was approximately $33.2 million, or $0.58 per share, compared to a net loss of $39.2 million, or $0.69 per share, in the prior year. This reduction in losses was largely due to decreased operating expenses, which fell by 25.8% to $44.9 million.

In terms of operational developments, Ispire has been focusing on expanding its manufacturing capabilities, having commenced operations at its facility in Malaysia in February 2024. The company received full licensure from the Malaysian government to manufacture nicotine products in March 2026, which is expected to enhance its production capacity. Additionally, Ispire is actively pursuing joint ventures, including a partnership with Chemular Inc. and Touch Point Worldwide, to develop age-verification technology for vaping products, which could potentially facilitate the approval of flavored e-cigarettes in the U.S. market.

The company’s customer base remains concentrated, with two distributors accounting for a significant portion of its revenue. As of June 30, 2026, Ispire had 57.8 million shares of common stock outstanding, with Tuanfang Liu and Jiangyan Zhu, both directors, holding a combined 66.5% of the company’s shares. The company has also been working on improving its internal controls, having identified material weaknesses in its financial reporting processes, which it aims to address through enhanced oversight and hiring of qualified personnel.

Looking ahead, Ispire Technology Inc. plans to continue its focus on product innovation and market expansion, particularly in the cannabis vaping sector, as legalization efforts progress in various regions. The company is also evaluating the potential for additional financing to support its growth initiatives, although it has expressed uncertainty regarding the availability of favorable terms. Overall, while Ispire faces challenges in a highly regulated and competitive market, its strategic developments and operational improvements may position it for future recovery and growth.